Search - tctmd.com

Displaying 21 - 40 of 171

Sort: Relevancy | Date

Presentation TCT 2025

Clinical Research After TRISCEND: Highest Priority Clinical Questions

Presenter: David J. Cohen

October 26, 2025

Presentation TCT 2025

Advancing TTVR: Are New Generation Devices Addressing Current Unmet Needs?

Presenter: Neil P. Fam

October 26, 2025

Presentation TCT 2025

TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

Presenter: Tobias Geisler

October 26, 2025

Presentation TCT 2025

The TRISCEND II Trial: Practice-Changing Implications

Presenter: Susheel K. Kodali

October 26, 2025

Presentation TCT 2025

TCT 988: Predictors of Heart Failure Hospitalization Events Following TTVR: Analysis from the Pooled TRISCEND Study and TRISCEND II Trial

Presenter: Anna Sannino

October 26, 2025

Presentation TCT 2025

Patient Selection for TTVR: Who Benefits, Who Doesn’t, and Why It Matters

Presenter: Thomas E. Waggoner

October 26, 2025

Presentation TCT 2025

TCT 986: Frailty as a Predictor of Clinical Outcomes Following Transcatheter Tricuspid Valve Repair (TTVR)

Presenter: Sultana Jahan

October 26, 2025

Presentation TCT 2025

TCT 983: A Novel TTVR System for Tricuspid Regurgitation: 2 Year Follow-up of the Early Compassionate Use Experience

Presenter: Jörg Hausleiter

October 26, 2025

Presentation TCT 2025

TCT 1311: Sapien Valve-in-Valve for Malpositioned Evoque TTVR

Presenter: Deven Ray Rajagopal

October 26, 2025

Presentation TCT 2025

TCT 1308: TTVR: EVOQUE Valve Complication & Lessons Learned

Presenter: David Kelley Roberts

October 26, 2025

Presentation TCT 2025

TCT 978: A Novel TTVR System: TRICURE EFS Study Update with a Recorded Case

Presenter: Pradeep K. Yadav

October 26, 2025

Presentation TCT 2025

When to Consider Heterotopic TTVR

Presenter: Fabio Sandoli de Brito

October 26, 2025

Presentation TCT 2025

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

Presenter: Santiago Garcia

October 26, 2025

Presentation TCT 2025

A Novel Strategy Targeting Caval Reflux to Alleviate Right Heart Failure in Severe Tricuspid Regurgitation: Early Results of the TRICAV EFS of TRIcvalve (Products+Features)

Presenter: Rishi Puri

October 26, 2025

Presentation TCT 2025

TCT 982: Clinical Characteristics and Outcomes of Transcatheter Tricuspid Valve Replacement (TTVR) Patients Stratified by TRISCEND II Trial Eligibility

Presenter: Sureja Sundaralingam

October 26, 2025

Presentation TCT 2025

Topaz

Presenter: Neil P. Fam

October 26, 2025

Presentation TCT 2025

Trisol

Presenter: Pradeep K. Yadav

October 26, 2025

Presentation TCT 2025

Lux

Presenter: Thomas Elie Modine

October 26, 2025

Presentation TCT 2025

VDyne

Presenter: Firas Zahr

October 26, 2025

Presentation TCT 2025

Laplace

Presenter: Kashish Goel

October 26, 2025

Advertisement

Clinical Research After TRISCEND: Highest Priority Clinical Questions

Advancing TTVR: Are New Generation Devices Addressing Current Unmet Needs?

TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

The TRISCEND II Trial: Practice-Changing Implications

TCT 988: Predictors of Heart Failure Hospitalization Events Following TTVR: Analysis from the Pooled TRISCEND Study and TRISCEND II Trial

Patient Selection for TTVR: Who Benefits, Who Doesn’t, and Why It Matters

TCT 986: Frailty as a Predictor of Clinical Outcomes Following Transcatheter Tricuspid Valve Repair (TTVR)

TCT 983: A Novel TTVR System for Tricuspid Regurgitation: 2 Year Follow-up of the Early Compassionate Use Experience

TCT 1311: Sapien Valve-in-Valve for Malpositioned Evoque TTVR

TCT 1308: TTVR: EVOQUE Valve Complication & Lessons Learned

TCT 978: A Novel TTVR System: TRICURE EFS Study Update with a Recorded Case

When to Consider Heterotopic TTVR

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

A Novel Strategy Targeting Caval Reflux to Alleviate Right Heart Failure in Severe Tricuspid Regurgitation: Early Results of the TRICAV EFS of TRIcvalve (Products+Features)

TCT 982: Clinical Characteristics and Outcomes of Transcatheter Tricuspid Valve Replacement (TTVR) Patients Stratified by TRISCEND II Trial Eligibility

Topaz

Trisol

Lux

VDyne

Laplace

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content